Viracta Therapeutics Inc (NASDAQ: VIRX) Has Succeeded In Attracting Investors This Year, The Stock Is Down -51.95% Year-To-Date
Viracta Therapeutics Inc (NASDAQ:VIRX)’s traded shares stood at 1.11 million during the latest session, with the company’s beta value hitting 0.71. At the last check